Carlos Colás Sanz

Prof. Dr. Carlos Colás Sanz

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Food & Function
Verified
Journal Article
Open access
PDF file
ATAna Pilar Tobajas
Ana Pilar Tobajas
AAAna Agulló-García
Ana Agulló-García
JCJose Luis Cubero
Jose Luis Cubero
CSCarlos Colás Sanz
Carlos Colás Sanz
ACAlba Civera
Alba Civera
MPMaría D. Pérez
María D. Pérez
Processing of Pru p 3 allergen with a food-grade fungal protease significantly degrades and reduces the allergenicity of Pru p 3 opening up new strategies for the food industry to reduce the allergenicity of peach-based products.

5 April 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
CSCarlos Colás Sanz
Carlos Colás Sanz
MÁMaría Elena Álvarez-Suárez
María Elena Álvarez-Suárez
LBLaura Benedito-Palos
Laura Benedito-Palos
IAIsam Alobid
Isam Alobid

12 June 2026 in Children
Verified
Journal Article
Open access
PDF file
SCSilvia Karina Carrión
Silvia Karina Carrión
LMLuis Martinez-Lostao
Luis Martinez-Lostao
CSCarlos Colás Sanz
Carlos Colás Sanz
Dr. David Jerves DonosoDr. David Jerves Donoso
Dr. David Jerves Donoso
Diego Fernández LázaroDiego Fernández Lázaro
Diego Fernández Lázaro
MEMaría Teresa Sobrevia Elfau
María Teresa Sobrevia Elfau
Background: Egg allergy is one of the most common food allergies in early childhood and is traditionally managed through strict avoidance diets, which may negatively affect nutrition and quality of life. Early oral immunotherapy (OIT) may represent an alternative therapeutic strategy; however, controlled studies in children younger than two years remain limited. Methods: We conducted a prospective observational study using historical controls. Thirty-one children younger than two years with IgE-mediated egg allergy underwent OIT using pasteurized liquid egg white (maximum dose: 30 mL; 3300 mg protein). Twelve children managed with an avoidance diet served as the historical control group. Outcomes included desensitization rates, adverse reactions, and longitudinal changes in skin prick test (SPT) wheal diameters, serum-specific IgE (sIgE), specific IgG4 (sIgG4), and sIgE/total IgE ratios. Results: At six months, 29/31 children (93.5%) in the OIT group did not experience allergic reactions after ingestion of any egg preparation, compared with none in the historical control group (p < 0.001). In the control group, 7/12 children (58.3%) continued to react to less-cooked egg preparations, whereas 5/12 (41.7%) remained reactive to all forms of eggs. During the induction phase, 24/31 OIT-treated children (77.4%) experienced mild adverse reactions, predominantly isolated cutaneous or gastrointestinal symptoms, and no patient required intramuscular adrenaline administration. In contrast, allergic reactions occurred in 11/12 controls, including anaphylaxis in 6/12 (50.0%) patients (p = 0.0301). The OIT group demonstrated significant reductions in SPT wheal diameters, sIgE levels, and sIgE/total IgE ratios (all p < 0.001), accompanied by increased sIgG4 levels. Conclusions: Early OIT with pasteurized egg white in children younger than two years with IgE-mediated egg allergy was associated with high desensitization rates, favorable short-term safety outcomes, and significant immunological changes. These findings support the potential role of early active intervention as an alternative to exclusive avoidance strategies in infants with egg allergy.